Respiratory syncytial virus–approved mAb Palivizumab as ligand for anti-idiotype nanobody-based synthetic cytokine receptors

Synthetic cytokine receptors can modulate cellular functions based on an artificial ligand to avoid off-target and/or unspecific effects. However, ligands that can modulate receptor activity so far have not been used clinically because of unknown toxicity and immunity against the ligands. Here, we d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ettich, Julia, Wittich, Christoph, Moll, Jens M., Behnke, Kristina, Floss, Doreen M., Reiners, Jens, Christmann, Andreas, Lang, Philipp A., Smits, Sander H.J., Kolmar, Harald, Scheller, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630626/
https://www.ncbi.nlm.nih.gov/pubmed/37734558
http://dx.doi.org/10.1016/j.jbc.2023.105270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630626/
https://www.ncbi.nlm.nih.gov/pubmed/37734558
http://dx.doi.org/10.1016/j.jbc.2023.105270

Ejemplares similares